• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Environmental Impact Acquisition Corp.

    7/6/21 5:19:57 PM ET
    $ENVI
    Get the next $ENVI alert in real time by email
    SC 13G 1 p21-1682sc13g.htm ENVIRONMENTAL IMPACT ACQUISITION CORP.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G
     
     
    Under the Securities Exchange Act of 1934
     
    (Amendment No.  )*
     

    Environmental Impact Acquisition Corp.

    (Name of Issuer)
     

    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)
     

    29408N106

    (CUSIP Number)
     

    June 23, 2021

    (Date of event which requires filing of this statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
     
    ¨ Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 6 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 29408N106

    13GPage 2 of 6 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Highbridge Capital Management, LLC

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    State of Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    1,087,024 shares of Class A Common Stock

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    1,087,024 shares of Class A Common Stock

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,087,024 shares of Class A Common Stock

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.25%

    12

    TYPE OF REPORTING PERSON

    IA, OO

             

     

     

    CUSIP No. 29408N106

    13GPage 3 of 6 Pages

     

     

    Item 1(a). NAME OF ISSUER:
       
      The name of the issuer is Environmental Impact Acquisition Corp. (the "Company").

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Company's principal executive offices are located at 535 Madison Avenue, New York, NY 10022.

     

    Item 2(a). NAME OF PERSON FILING:
    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    Item 2(c). CITIZENSHIP:

     

      This statement is filed by:

     

      (i)

    Highbridge Capital Management, LLC

    277 Park Avenue, 23rd Floor

    New York, New York 10172

    Citizenship: State of Delaware

     

      The foregoing person is hereinafter sometimes referred to as the "Reporting Person."  

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock").

     

    Item 2(e). CUSIP NUMBER:
       
      29408N106

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act,
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act,
      (c) ¨ Insurance Company as defined in Section 3(a)(19) of the Act,
      (d) ¨ Investment Company registered under Section 8 of the Investment Company Act of 1940,
      (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E),
      (f) ¨ Employee Benefit Plan or Endowment Fund in accordance with Rule 13d-1(b)(1)(ii)(F),
      (g) ¨ Parent Holding Company or control person in accordance with Rule 13d-1(b)(1)(ii)(G),

     

     

    CUSIP No. 29408N106

    13GPage 4 of 6 Pages

     

     

      (h) ¨ Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act,
      (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
      (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

    specify the type of institution:                                                                                        

     

    Item 4. OWNERSHIP.

     

        (a) Amount beneficially owned:

     

      As of the date hereof, Highbridge Capital Management, LLC, as the trading manager of Highbridge Tactical Credit Master Fund, L.P. and Highbridge SPAC Opportunity Fund, L.P. (collectively, the "Highbridge Funds"), may be deemed to be the beneficial owner of the 1,087,024 shares of Class A Common Stock held by the Highbridge Funds.  

     

        (b) Percent of class:

     

      The percentages used herein and in the rest of this Schedule 13G are calculated based upon 20,700,000 shares of Class A Common Stock reported to be outstanding as of May 24, 2021, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 filed with the Securities and Exchange Commission on May 24, 2021.  Therefore, as of the date hereof, Highbridge Capital Management, LLC may be deemed to beneficially own approximately 5.25% of the outstanding shares of Class A Common Stock.  

     

      The foregoing should not be construed in and of itself as an admission by the Reporting Person as to beneficial ownership of the shares of Class A Common Stock held by the Highbridge Funds.

     

        (c) Number of shares as to which such person has:

     

          (i) Sole power to vote or to direct the vote
             
            0
           
          (i) Sole power to vote or to direct the vote
             
            0
             
          (ii) Shared power to vote or to direct the vote
             
            See Item 4(a)

     

     

    CUSIP No. 29408N106

    13GPage 5 of 6 Pages

     

     

          (iii) Sole power to dispose or to direct the disposition of
             
            0
             
          (iv) Shared power to dispose or to direct the disposition of
             
            See Item 4(a)

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      Not applicable.

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      See Item 4.

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.

     

      The Reporting Person hereby makes the following certification:
       
      By signing below the Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    CUSIP No. 29408N106

    13GPage 6 of 6 Pages

    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATED: July 6, 2021

     

    HIGHBRIDGE CAPITAL MANAGEMENT, LLC
         
         
    By: /s/ Kirk Rule  
    Name: Kirk Rule  
    Title: Executive Director  
         

     

    Get the next $ENVI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENVI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ENVI
    Leadership Updates

    Live Leadership Updates

    See more
    • Greenlight Biosciences (ENVI) Adds Two World-Renowned Scientists To Its Scientific Advisory Board

      BOSTON, Nov. 4, 2021 /PRNewswire/ -- GreenLight Biosciences is delighted to announce the appointment of Professor Diane E. Griffin, MD, PhD, and Emmanuel Hanon, DVM, PhD, to its Human Health Scientific Advisory Board. At Johns Hopkins University, Diane Griffin is the Distinguished Service Professor, a professor of Medicine and Neurology at the School of Medicine, and the W. Harry Feinstone professor at the Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health. She has also been vice president of the U.S. National Academy of Sciences since

      11/4/21 10:02:00 AM ET
      $ENVI
    • GreenLight Biosciences Announces the Appointment of Jennifer Raymond As SVP, CMC and Manufacturing

      BOSTON, Sept. 16, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, announced the appointment of Jennifer Raymond as SVP, CMC & Manufacturing today. Raymond joins GreenLight from GSK with more than 23 years of experience in the pharmaceutical industry, including 13 years in vaccines development, production, and Quality Assurance, across Merck, Novartis, and GSK. She has comprehensive first-hand experience in both R&D and Operations in small and large scale biological platforms (mammalian, viral, bacterial). Raymond's recent work includes development and launch of specialty biophar

      9/16/21 12:02:00 PM ET
      $ENVI

    $ENVI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • GreenLight Biosciences begins trading today as Nasdaq: GRNA on the closing of its business combination with Environmental Impact Acquisition Corp.

      BOSTON, Feb. 3, 2022 /PRNewswire/ -- GreenLight Biosciences ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp. (NASDAQ:ENVI) ("ENVI"), a special purpose acquisition company, yesterday announced the closing of their previously announced business combination. In connection with the closing, the company changed its name to GreenLight Biosciences Holdings, public-benefit corporation, with shares of Class A common stock and public warrants

      2/3/22 10:02:00 AM ET
      $ENVI
    • Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022

      BOSTON, Feb. 2, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ:ENVI), a publicly-traded special purpose acquisition company, announced today that its business combination with Greenlight Biosciences was approved in a shareholder vote held yesterday, with 80.7% of shareholders participating in the vote and 78.6% voting in favor of the combination. Subject to the satisfaction or waiver of the other customary closing conditions, Environmental Impact Acquisition Corp. anticipates closing the business combination today. In connection with the closing, the

      2/2/22 8:58:00 AM ET
      $ENVI
    • GreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control Pests

      BOSTON, Jan. 31, 2022 /PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership agreement that could lead to the first commercial use of RNA as a seed treatment to control crop diseases and offer options to farmers looking for innovative solutions. Through the partnership, the two companies will explore synergies between Germains' seed priming and coating technologies and GreenLight's dsRNA expertise and ability to cost-effectively scale manufacturing to protect vegetable crops

      1/31/22 10:40:00 AM ET
      $ENVI

    $ENVI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Environmental Impact Acquisition Corp.

      SC 13G - Environmental Impact Acquisition Corp (0001822691) (Subject)

      7/6/21 5:19:57 PM ET
      $ENVI

    $ENVI
    SEC Filings

    See more
    • SEC Form 425 filed by Environmental Impact Acquisition Corp.

      425 - Environmental Impact Acquisition Corp (0001822691) (Subject)

      2/2/22 8:34:52 AM ET
      $ENVI
    • Environmental Impact Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Environmental Impact Acquisition Corp (0001822691) (Filer)

      2/2/22 8:32:05 AM ET
      $ENVI
    • SEC Form 425 filed by Environmental Impact Acquisition Corp.

      425 - Environmental Impact Acquisition Corp (0001822691) (Subject)

      1/28/22 9:10:59 AM ET
      $ENVI

    $ENVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Walker Matthew Alan was granted 14,343,021 shares and bought $15,000,000 worth of shares (1,500,000 units at $10.00)

      4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      2/4/22 8:22:17 PM ET
      $ENVI
    • SEC Form 3 filed by new insider Walker Matthew Alan

      3 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      2/4/22 8:20:21 PM ET
      $ENVI
    • SEC Form 4 filed by Keefe Susan

      4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      2/4/22 8:01:51 PM ET
      $ENVI